Cognizant slides 6.7% as investors weigh legal overhang and a risk-off tape ahead of earnings

Cognizant Technology Solutions (CTSH) is down 6.7% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop looks driven by a mix of broader risk-off sentiment in IT/services names and renewed attention to company-specific legal uncertainty tied to its TriZetto unit. With Cognizant set to report quarterly results soon, investors may also be de-risking into the print after a strong run-up earlier in the year.

Details:

Cognizant scheduled its first-quarter 2026 earnings release for April 29, 2026, putting the stock in a “pre-earnings” window where positioning can amplify day-to-day moves.

TriZetto (a Cognizant unit) has faced proposed class-action claims tied to an alleged data breach, which can increase perceived headline and expense risk even before any financial impact is quantified.

Separate TriZetto-related litigation has remained active in recent weeks, keeping an ongoing legal narrative around the business in the market.

Multiple analysts have lowered price targets in April, which can pressure sentiment and reduce dip-buying when the sector turns defensive.

Sources:

Cognizant Investor Relations, Law360, Investing.com, MarketBeat

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CTSH Insider Trading Activity

$CTSH insiders have traded $CTSH stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.

Here’s a breakdown of recent trading of $CTSH stock by insiders over the last 6 months:

MICHAEL PATSALOS-FOX has made 0 purchases and 7 sales selling 25,000 shares for an estimated $2,102,593.
SURYA GUMMADI (President - Americas) has made 0 purchases and 4 sales selling 22,728 shares for an estimated $1,797,954.
JOHN SUNSHIN KIM (CLO, CAO & Corporate Secretary) has made 0 purchases and 3 sales selling 10,000 shares for an estimated $806,355.
RAVI KUMAR SINGISETTI (Chief Executive Officer) has made 0 purchases and 2 sales selling 6,075 shares for an estimated $500,974.
ALINA KERDMAN (SVP, Controller & CAO) has made 0 purchases and 5 sales selling 767 shares for an estimated $53,960.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EARLY ACCESS

Receive CTSH Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CTSH Hedge Fund Activity

We have seen 474 institutional investors add shares of $CTSH stock to their portfolio, and 498 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 13,533,313 shares (-75.8%) from their portfolio in Q4 2025, for an estimated $1,123,264,979
GQG PARTNERS LLC added 8,116,278 shares (+inf%) to their portfolio in Q4 2025, for an estimated $673,651,074
CITADEL ADVISORS LLC added 6,503,526 shares (+1033.0%) to their portfolio in Q4 2025, for an estimated $539,792,658
BLACKROCK, INC. removed 6,080,951 shares (-12.0%) from their portfolio in Q4 2025, for an estimated $504,718,933
FMR LLC removed 5,587,444 shares (-60.9%) from their portfolio in Q4 2025, for an estimated $463,757,852
QUBE RESEARCH & TECHNOLOGIES LTD removed 2,296,820 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $190,636,060
PACER ADVISORS, INC. removed 2,187,045 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $181,524,735

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CTSH Congressional Stock Trading

Members of Congress have traded $CTSH stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CTSH stock by members of Congress over the last 6 months:

REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/17.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 03/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CTSH Analyst Ratings

Wall Street analysts have issued reports on $CTSH in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

William Blair issued a "Outperform" rating on 11/21/2025
Wells Fargo issued a "Overweight" rating on 10/30/2025
JP Morgan issued a "Overweight" rating on 10/30/2025

To track analyst ratings and price targets for $CTSH, check out Quiver Quantitative's $CTSH forecast page.

$CTSH Price Targets

Multiple analysts have issued price targets for $CTSH recently. We have seen 12 analysts offer price targets for $CTSH in the last 6 months, with a median target of $83.0.

Here are some recent targets:

Jonathan Lee from Guggenheim set a target price of $85.0 on 04/22/2026
Kevin Mcveigh from UBS set a target price of $64.0 on 04/13/2026
David Koning from Baird set a target price of $72.0 on 04/10/2026
Steven Wahrhaftig from Wedbush set a target price of $61.0 on 04/09/2026
Bryan Keane from Citigroup set a target price of $68.0 on 04/07/2026
Bryan C. Bergin from TD Cowen set a target price of $71.0 on 03/13/2026
James Faucette from Morgan Stanley set a target price of $82.0 on 02/05/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.